Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Protein Variants

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search

Search term:

Results 1 - 10 of 29 > >>
download as CSV
download all results as CSV
EC Number Protein Variants Commentary Reference
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.B62C698A mutant is able to glucosylate Rac protein but does not display cytotoxicity. Mutant does not show autocatalytical activity 727860
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.B62C698A site-directed mutagenesis of the autoprocessing domain, mutant TcsL C698A is able to quickly glucosylate Rac1, similar to wild-type TcsL, but is attenuated in its ability to glucosylate Ras GTPases. The introduction of the autoprocessing mutation does not impact the glucosylation of Rac1 or H-Ras in an in vitro assay -, 759813
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.B62D587N mutant is able to glucosylate Rac protein but does not display cytotoxicity. Mutant does not show autocatalytical activity 727860
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.B62F17K mutation strongly decreases binding to brain phosphatidylserine 737283
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.B62F17N/R18A site-directed mutagenesis in the GTD membrane localization domain, on the surface of the membrane localization domain (MLD), the mutant shows a defect in membrane association in a liposome binding assay -, 759813
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.B62F17N/R18A/C698A site-directed mutagenesis in the GTD membrane localization domain, on the surface of the membrane localization domain (MLD), the mutant shows a defect in membrane association in a liposome binding assay. The triple mutant is also inhibited in both Rac1 and Ras glucosylation -, 759813
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.B62H653A mutant is able to glucosylate Rac protein but does not display cytotoxicity. Mutant does not show autocatalytical activity 727860
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.B62I383S mutation in toxin B, 67% of wild-type catalytic efficiency with substrate UDP-alpha-D-glucose -, 727851
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.B62I383S/Q385A mutation allow modification of Ras in the presence of UDP-N-acetyl-glucosamine and reduces the acceptance of UDP-glucose as a donor for glycosylation -, 727851
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.B62I383S/Q385A mutation in toxin B, 23% of wild-type catalytic efficiency with substrate UDP-alpha-D-glucose. Mutation largely increases the acceptance of UDP-Nacetylglucosamine as a sugar donor for modification of RhoA -, 727851
Results 1 - 10 of 29 > >>
download as CSV
download all results as CSV